Previous 10 | Next 10 |
Alcentra (NASDAQ: ABDC ): Q3 GAAP NII of $0.13 misses by $0.05 . Total investment income of $5.6M (-14.5% Y/Y) misses by $0.58M . Press Release More news on: Alcentra Capital Corporation, Earnings news and commentary, Financial stocks news, ,
NEW YORK , Nov. 5, 2019 /PRNewswire/ -- Alcentra Capital Corporation (NASDAQ: ABDC) (the "Company"), a provider of debt financing solutions to middle-market companies based primarily in the United States , today announced its financial results for the third quarter of 2019. Third Qua...
Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...
NEW YORK , Oct. 14, 2019 /PRNewswire/ -- Alcentra Capital Corporation (NASDAQ: ABDC) ("Alcentra Capital" or the "Company"), a provider of debt financing solutions to middle-market companies based primarily in the United States , announced today that its Board of Directors declared a...
Merger activity increased last week with five new deals announced and five deals closing. Deal Statistics: New Deals: The acquisition of Dova Pharmaceuticals (DOVA) by Swedish Orphan Biovitrum AB (BIOVF) for $915 million. Under the terms of the agreement, Dova stockholders will ...
Merger activity remained unchanged last week with two new deals announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Alder BioPharmaceuticals (ALDR) by H. Lundbeck A/S for $1.95 billion. Under the terms of the agreement, Alder stockholders will be of...
Merger activity increased last week with two new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of United Community Financial (UCFC) by First Defiance Financial (FDEF) for $473 million in an all-stock deal. Under the terms of the merger agre...
NEW YORK , Aug. 17, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City , is investigating: Presidio, Inc. ( PSDO ) ("Presidi...
It's been over a year since the 8/9/2018 announcement that Medley Management ( MDLY ) and Medley Capital ( MCC ) were planning to merge with Sierra Income to form the 2nd largest internally managed Business Development Corporation. These are all related companies. MDLY now manages both MCC...
Deciphera Pharmaceuticals (NASDAQ: DCPH ) +121% on positive late-stage ripretinib data . More news on: Deciphera Pharmaceuticals, Inc., DelMar Pharmaceuticals, Inc., Alcentra Capital Corporation, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Alcentra Capital Corp. Company Name:
ABDC Stock Symbol:
NASDAQ Market:
Alcentra Capital Corp. Website:
LOS ANGELES, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) today announced that on January 29, 2020 it received stockholder approval on all proposals required in connection with the definitive merger agreement under which Crescent BDC will acqui...
NEW YORK , Jan. 30, 2020 /PRNewswire/ -- Alcentra Capital Corporation ("Alcentra Capital") (NASDAQ: ABDC) today announced that over 98% of stockholders who voted at its special meeting of stockholders held on January 29, 2020 cast their votes in favor of the proposed merger (the "Merger...
NEW YORK , Jan. 28, 2020 /PRNewswire/ -- Alcentra Capital Corporation (NASDAQ: ABDC) (" Alcentra Capital " or the " Company ") today announced that, due to the contingent nature of its final dividend, Nasdaq has informed the Company that stockholders who sell their shares of Alc...